ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.637,53
0,93%
S&P 500
6.039,31
-0,47%
Dow Jones
44.713,52
-0,31%
Euro vs US Dollar
1,04188
-0,09%
Bitcoin
103.676,62
2,31%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rhythm Pharmaceuticals Inc (RYTM)

  7. Rhythm Pharmaceuticals Inc (RYTM) News

RYTM

Rhythm Pharmaceuticals (RYTM)

Rhythm Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RYTM
DatumZeitQuelleÜberschriftSymbolFirma
10/01/202513h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
10/01/202513h15GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming MilestonesNASDAQ:RYTMRhythm Pharmaceuticals Inc
20/12/202420h15GlobeNewswire Inc.Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years OldNASDAQ:RYTMRhythm Pharmaceuticals Inc
03/12/202412h00GlobeNewswire Inc.Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to inclNASDAQ:RYTMRhythm Pharmaceuticals Inc
18/11/202413h00GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with SetmelanotideNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/11/202403h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/11/202403h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/11/202403h01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RYTMRhythm Pharmaceuticals Inc
14/11/202400h30GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & EndocrinologyNASDAQ:RYTMRhythm Pharmaceuticals Inc
13/11/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
12/11/202413h55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
08/11/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
07/11/202422h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/11/202423h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/11/202414h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
06/11/202414h00GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation in Upcoming Investor ConferencesNASDAQ:RYTMRhythm Pharmaceuticals Inc
05/11/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
05/11/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
04/11/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
24/10/202412h00GlobeNewswire Inc.Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl SyndromeNASDAQ:RYTMRhythm Pharmaceuticals Inc
23/10/202414h00GlobeNewswire Inc.Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
08/10/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
19/09/202422h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
16/09/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/09/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
28/08/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
26/08/202422h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
26/08/202414h02GlobeNewswire Inc.Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years oldNASDAQ:RYTMRhythm Pharmaceuticals Inc
26/08/202414h00GlobeNewswire Inc.Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in SeptemberNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/08/202422h06Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:RYTMRhythm Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RYTM

Kürzlich von Ihnen besucht

CCOM
SILVER
SILVER
CCOM
US30
US 30
TG
BAS
BASF
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
FX
EURUSD
Euro vs US Dollar
TG
ALV
Allianz
USOTC
BASFY
BASF (QX)
AMEX
SPY
SPDR S&P 500
TG
TUI1
Tui
TG
LHA
Deutsche Lufthansa
DBI
DAX
DAX
TG
D7G
Nel ASA
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten